Ken Griffin Bio Techne Corp Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Techne Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 2,470,862 shares of TECH stock, worth $132 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,470,862
Previous 7,200
34217.53%
Holding current value
$132 Million
Previous $422,000
30024.41%
% of portfolio
0.02%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding TECH
# of Institutions
614Shares Held
161MCall Options Held
225KPut Options Held
80.8K-
Vanguard Group Inc Valley Forge, PA18.4MShares$985 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$801 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.85MShares$473 Million0.05% of portfolio
-
Morgan Stanley New York, NY6.58MShares$351 Million0.02% of portfolio
-
State Street Corp Boston, MA5.86MShares$313 Million0.01% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.1B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...